Please login to the form below
Healthcare terms - T
A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W |
Healthcare Glossary
A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W |
Healthcare terms - T
- Tactical planning
- Tagging
- Target audience
- Target publications
- Tariffs
- Technical efficiency (pharmacoeconomics)
- Telesales
- Terms and conditions of purchase
- Terms and conditions of sale
- Territory
- Territory management
- Test marketing
- Testimonials
- Therapy area
- Tonal bias
- Tone of the media
- Top-of-mind awareness (TOMA)
- Toxicity
- Trade advertising
- Trade allowance
- Trade barriers
- Trade publications
- Trademark
- Transfer price
- Treatment Investigational New Drug (IND)
- Treatment trials
- Treatment trials
- Trend analysis
- Trial endpoint
- Trial stage
Featured jobs
- Experienced / Senior Medical Writer - MedComms - Cardiff - Wales
-
Excellent Salary and Benefits on offer
- Account Director, Healthcare Communications Agency
-
£54, 000- £60, 000
- Senior / Principal Medical Writer – Medical Education - UK &...
-
Excellent Salary and Benefits on offer
-
Senior Medical Writer
-
Salary TBC
- Senior Medical Writer– Medical Education – Oxford - London
-
Excellent Remuneration Package
- Account Manager / Senior Account Manager - Creative MedComms - C...
-
Excellent Remuneration
-
Account Director, Medical Education
-
Salary TBC
- Senior Medical Writer – Leading Medical Communications Agency – ...
-
Highly Competitive Remuneration Package
- Scientific Director - Medical Communications Agency - New York
-
Excellent Remuneration Package
- Graduate / Entry Level Opportunities – Medical Communications – ...
-
Highly Competitive Remuneration Package
- Scientific Director - Medical Education - Cheshire & London ...
-
Excellent Remuneration Package
Subscribe to our email news alerts
- AstraZeneca’s Calquence impresses in previously untreated CLL
- UCB’s bimekizumab beats AbbVie’s Humira in phase 3 trial
- Novartis highlights emerging assets and late-stage pipeline at R&D day
- Novartis strengthens case for its combination asthma drug
- Biogen defends aducanumab filing plan amid scepticism
- Armed with new data, BMS plans filings for Celgene CAR-T liso-cel
- AZ, Daiichi Sankyo strengthen case for HER2 candidate
- Biologic patent exclusivity scrapped in new US trade deal
- UCB/Amgen’s Evenity finally cleared for osteoporosis in Europe
- Intec battered as Novartis ducks out of Accordion collaboration
- J&J appeals Oklahoma opioid verdict, claiming ‘errors’ in trial
- BMS’ oral maintenance therapy boosts survival in AML patients
PMHub
Valid Insight
Valid Insight is an award-winning pharmaceutical global market access consultancy....
Quick links
Infographics
